Significant Ownership of Medtronic plc
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Medtronic plc focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Brian Sandstrom - Brian Sandstrom/VP, Chief Corporate and Securities Counsel
- Manager location
- Galway
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Medtronic plc with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Medtronic plc
Significant Ownership of Medtronic plc
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MMED | MiniMed Group, Inc. | Common Stock, par value $0.01 per share | 90% | $3,637,984,078 | 252,813,348 | Medtronic plc | 31 Mar 2026 | ||
| OBIO | Orchestra BioMed Holdings, Inc. | Common Stock, Par Value $0.0001 Per Share | 18% | $41,826,294 | +$17,470,292 | 10,078,625 | +72% | Medtronic plc | 31 Dec 2025 |
| AVR | Anteris Technologies Global Corp. | Common Stock | 16% | $78,107,474 | 15,652,173 | Medtronic plc | 22 Jan 2026 |
Schedules 13D/G Reported by Medtronic plc:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.